Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

This study has been terminated.
(Safety concerns)
Information provided by:
Achillion Pharmaceuticals Identifier:
First received: June 21, 2002
Last updated: December 29, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2003
  Estimated Primary Completion Date: No date given